AdAlta Ltd.ASX: 1AD

Institutional investment to pursue strategic initiatives

· Issued by AdAlta Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

The investment comprises contributions from New Life Sciences Capital LLC and the Meurs Group, providing AdAlta with financial flexibility for its ongoing projects. The funds will primarily be used to accelerate progress on a recently announced partnership with SYNthesis BioVentures and to advance internal i-body programs.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

AdAlta Ltd. on 6ix

In the deck

Earlier from AdAlta

Later from AdAlta

All AdAlta news releases